Wikipedia -WSS

Wikipedia

author：explore 2025-09-06 06:06:58 - browse：62

After earning her doctorate in cell biology at the University of Pennsylvania in June, Sierra Collins did what many freshly minted Ph.D.s. do — she went looking for a job at a biotech company. But what was supposed to be a straightforward search has turned into an odyssey.

Collins has applied for more than 53 positions (and counting). Like a good scientist, she’s gathering data along the way and uses a spreadsheet to track each company’s size and therapeutic focus, as well as whether she was referred for the position and how far she made it through the application process. So far, those efforts have been unsuccessful.

“I try my best not to take it personally. These are companies that are trying to find an employee who’s going to help them achieve their business goals,” Collins said. “But it is pretty discouraging just repeatedly getting turned down, especially at later stages of the interview process.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

entertainment

WSS

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Medicare to cover more brain scans for Alzheimer’s patients

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Google and Epic fight stronger regulation of AI in health care

Chemotherapy shortages won’t get better under Biden’s latest plan

explore

Wikipedia

hotspot

Apple is now the first public company to be valued at $3 trillion

Cosmetics set for new safety regulation. Why the industry is on board

Continuity nursing helped my family in our darkest PICU moments

FDA needs staff influx to meet gene therapy needs, Marks says

Alkermes shareholders re

In diabetes hearing, Sanders takes on a new foe: food makers

Walensky prepares to leave CDC — and Congress — behind

As digital health tech proliferates, a new institute aims to cut through hype

Wildfire smoke exposes gaps in outdoor worker protections

What PEPFAR has meant on the ground in Ukraine

focus

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Chemotherapy shortages won’t get better under Biden’s latest plan

In diabetes hearing, Sanders takes on a new foe: food makers

Startup Neumora takes a novel depression drug to Phase 3

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

FDA approves RSV monoclonal antibody for infants, toddlers

focus

entertainment

knowledge

focus